Anika Therapeutics (ANIK) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $20.36 -2.54%
EPS Growth %: -25.0%
Financial Fact:
Total revenue: 25.79M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -25.0%
Financial Fact:
Total revenue: 25.79M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Anika Therapeutics (NASDAQ: ANIK) reported Q1 EPS of ($0.06), $0.02 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $26.17 million versus the consensus estimate of $28.13 million.
For earnings history and earnings-related data on Anika Therapeutics (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paramount Weighs Tapping Musk For Equity Investment - Semafor
- DelphX closes C$61,000 non-brokered private placement
- McDonald's (MCD) Said August In Us Business Was 'slightly Negative' - Bloomberg
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
